← Leaderboards
Eric Hutton Raabe
Johns Hopkins University
$804,830
Attributed
$1,609,659
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $456.6K · FY2018–21$500K$375K$250K$125K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$1,609,659 · 1
By mechanism
R01$1,609,659 · 1
Top collaborators
- Barbara Stauch Slusher4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Chi V. Dang$24,535,395
- Robert H Gilman$35,342,766
- Cynthia L Sears$16,773,568
- Andrew M Cameron$6,342,614
- Dorry Segev$40,743,790
Others in their field
Other Emerging Leaders on “Esters”
- Tony Yuen · Icahn School Of Medicine At Mount Sinai$8,061,604
- Vaia Lida Chatzi · University Of Southern California$7,873,552
- Nikej Shah · Nirsum Laboratories, Inc.$7,640,042
- Joshua Wiley Knowles · Stanford University$6,163,002
- Paul Cohen · Rockefeller University$5,891,007
- Li Ye · Stanford University$5,701,260
Research focus
Esters10 Year OldAcuteAnimal ModelBaseBehavior AssessmentBrainBrain NeoplasmsBrain PathologyCandidate SelectionCell ModelCellsChemical StabilityChemistryChemotherapyChildCleaved CellClinical TrialsDesignDoseDrug DiscoveryDrug KineticsEarly Detection BiomarkersExhibits
Grant awards (4)
Novel brain penetrant metabolic inhibitors to treat MYC-driven medulloblastoma$456,591
R01 · FY2021 · NS
Novel brain penetrant metabolic inhibitors to treat MYC-driven medulloblastoma$384,346
R01 · FY2020 · NS
Novel brain penetrant metabolic inhibitors to treat MYC-driven medulloblastoma$384,361
R01 · FY2019 · NS
Novel brain penetrant metabolic inhibitors to treat MYC-driven medulloblastoma$384,361
R01 · FY2018 · NS